Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001813798-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-02 | 2026-02-27+ | PCVX | Wassil Jim | COO | F - Tax | $61.86 | -3,807 | 175.2K | -2% | -$235.5K |
| DM | 2026-03-02 | 2026-02-26+ | PCVX | Wassil Jim | COO | A - Grant | $8.48 | +37.1K | 173.9K | +27% | +$315.0K |
| D | 2026-03-02 | 2026-02-26 | PCVX | Wassil Jim | COO | A - Grant | $0.00 | +53.6K | 53.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-28 | F | D | 898 | $61.98 | 176,197 | D | — | — | (F3) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
| 2 | Common | Common Stock | 2026-02-27 | F | D | 1,900 | $61.74 | 177,095 | D | — | — | (F3) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
| 3 | Common | Common Stock | 2026-02-27 | A | A | 5,102 | $61.74 | 178,995 | D | — | — | (F2) Represents RSUs issued in lieu of a cash bonus by election of the Reporting Person, such election available to all of Issuer's senior management. The RSUs are fully vested upon the date of grant. |
| 4 | Common | Common Stock | 2026-02-26 | A | A | 32,045 | $0.00 | 173,893 | D | — | — | (F1) Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 1/4 of the shares subject to the award on September 7, 2026 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
| 5 | Common | Common Stock | 2026-03-02 | F | D | 1,009 | $61.98 | 175,188 | D | — | — | (F3) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
| 6 | Derivative | Stock Option (right to buy) | 2026-02-26 | A | A | 53,566 | $0.00 | 53,566 | D | $60.00 · — to 2036-02-26 | 53,566 Common Stock | (F4) 1/48 of shares subject to the option vest on March 26, 2026, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |